A. Karim Kader, MD, PhD, presented “Clinical Implications of Genetics in Prostate Cancer” during the 30th Annual International Prostate Cancer Update on January 23rd, 2020 in Beaver Creek, Colorado.
How to cite: Kader, A. Karim. “Clinical Implications of Genetics in Prostate Cancer” January 23rd, 2020. Accessed Mar 2024. https://grandroundsinurology.com/clinical-implications-of-genetics-in-prostate-cancer/
Clinical Implications of Genetics in Prostate Cancer – Summary:
A. Karim Kader, MD, PhD, Professor in the Department of Urology and Director of Urologic Oncology at the University of California, San Diego, discusses the use of genetic and genomic prostate cancer markers as a risk assessment tool in men from screening to post-treatment workup. He describes several case studies in-depth, notes what markers were used for each individual case, and details the patient-specific outcomes associated with each case.
About The 30th Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. Dr. Kader gave this presentation during the 30th iteration of the meeting in January 2020.
For further educational activities from this conference, visit our collection page.